Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Arie Belldegrun
Recent news which mentions Arie Belldegrun
Biotech attracts Arie Belldegrun after back-to-back Big Pharma deals
September 29, 2020
Tags
Merck & Co/, Inc/
Tishman Speyer
Insurance
From
Business Journals
Neogene Therapeutics raises $110M to develop neo-antigen T cell therapies for cancer
September 14, 2020
Tags
Startups
Arie Belldegrun
Carsten Linnemann
From
Business Journals
'This can happen to anyone': How this cell therapy pioneer, diagnosed with the coronavirus, wants to destigmatize COVID-19
March 17, 2020
Tags
Allogene Therapeutics, Inc/
Hospitals
Biotech
From
Business Journals
'This can happen to anyone': How this cell therapy pioneer, diagnosed with the coronavirus, wants to destigmatize COVID-19
March 16, 2020
Tags
Gladstone Institutes
Health Care
Pharmaceuticals
From
Business Journals
Kronos Bio backer’s VC firm raises $600M for life science investments
August 01, 2019
Tags
Private equity
Biotech
Merck & Co/
From
Business Journals
Meet Facebook's new neighbor: Cutting-edge cell therapy company lands big East Bay space
February 20, 2019
Tickers
JLL
Tags
Pharmaceuticals
Health Care
JLL
From
Business Journals
Cell therapy pioneer eyes Bay Area manufacturing
January 09, 2019
Tags
Biotech
Manufacturing
Allogene Therapeutics, Inc/
From
Business Journals
Why a Peninsula cancer fighter soared nearly 40% after record-breaking IPO
October 11, 2018
Tags
Arie Belldegrun
Pharmaceuticals
Pfizer, Inc/
From
Business Journals
Health Care Digest: Upsized record IPO, e-cigarette questions, a CEO Dance and more
October 08, 2018
Tags
MannKind Corp/
Padmanee Sharma
Clarus Ventures (Cambridge MA)
From
Business Journals
This cancer-fighting biotech sped from startup to IPO filing in 10 months
September 17, 2018
Tags
Bluebird Bio
Atara Biotherapeutics Inc/ (South San Francisco CA)
Arie Belldegrun
From
Business Journals
He helped Gilead score billions from HIV, hepatitis C drugs — now he's building a cancer fighter
May 22, 2018
Tags
Health Care
Pharmaceuticals
John Martin
From
Business Journals
Kite Pharma A Top Pick Ahead Of Axi-Cel Launch
June 27, 2017
Tickers
KITE
NEWS
Tags
Axi/Cel
KITE
Cowen
From
Benzinga
Kite Pharma CEO: 'We Are Offering The Next Generation Immunotherapy'
June 24, 2015
Tickers
BLUE
CNBC
KITE
Tags
Media
KITE
BLUE
From
Benzinga
Opko, Frost invest in developmental biotech company
October 30, 2013
Tickers
OPK
Tags
Arie Belldegrun
Phillip Frost
David Bonderman
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.